This site is intended for health professionals only
Tuesday 25 September 2018
Share |

New drug "can reduce brain tumour size"

Related articles

The UK’s National Health Service turned 70 this month, and while we celebrate the achievements of one of the nation’s most valuable institutions, it’s also the perfect opportunity to pinpoint the role that pharmacy has played in the NHS during those decades.
PHARMACY AND THERAPEUTICS

The New England Journal of Medicine (NEJM) has published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS).

This study, which was previously presented at the 46th American Society of Clinical Oncology annual meeting, is the first prospective clinical trial of a drug to show treatment benefit in these patients.
 

Ads by Google